Racial/ethnic representation and disparities in preclinical cancer models
I sure as shit did
Practitioners prescribing semaglutide 0.15 mg, 0.25 mg per week - Microdoses -for conditions never studied, at doses never proven effective, based on a daisy chain of: Mouse studies that dont translate Dose-response curves that show threshold effects requiring higher doses Social media testimonials And wishful thinking From an insurance perspective, we cannot reimburse treatments without evidence of efficacy
And thats kind of the lesson were learning as we learn more and more about GLP-1 medication, said Marzouk
Jonas AJ, Conley SB, Marshall R, Johnson RA, Marks M, Rosenberg H (1987) Nephropathic cystinosis with central nervous system involvement
Finally, MRAB-3 biofilms were also subjected to a three-part combination treatment: 30 mM GSH + 40U DNase-I + 4 g/mL amikacin